ACADIA Pharmaceuticals Inc (ACAD)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 938,318 | 616,125 | 507,937 | 617,823 | 717,616 |
| Total current liabilities | US$ in thousands | 394,870 | 254,254 | 125,630 | 96,068 | 105,967 |
| Current ratio | 2.38 | 2.42 | 4.04 | 6.43 | 6.77 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $938,318K ÷ $394,870K
= 2.38
ACADIA Pharmaceuticals Inc's current ratio has shown a declining trend over the last five years, decreasing from 6.77 in December 2020 to 2.38 in December 2024. A current ratio of 6.77 in 2020 indicates the company had a strong ability to cover its short-term liabilities with its current assets, but the ratio has gradually decreased over the following years.
The current ratio of 2.38 as of December 31, 2024, suggests that the company may be experiencing some liquidity challenges as its current assets may not be as sufficient to cover its current liabilities. While a ratio above 1 generally indicates a company can meet its short-term obligations, a ratio significantly below 2 may raise concerns about its ability to repay debts or fund operations in the short term.
It is recommended for stakeholders to monitor ACADIA Pharmaceuticals Inc's liquidity position and assess the reasons behind the decreasing current ratio trend in order to understand the company's financial health and ability to manage its short-term obligations effectively.
Peer comparison
Dec 31, 2024